Literature DB >> 24274415

From "ES-like" cells to induced pluripotent stem cells: a historical perspective in domestic animals.

Sehwon Koh1, Jorge A Piedrahita.   

Abstract

Pluripotent stem cells such as embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) provide great potential as cell sources for gene editing to generate genetically modified animals, as well as in the field of regenerative medicine. Stable, long-term ESCs have been established in laboratory mouse and rat; however, isolation of true pluripotent ESCs in domesticated animals such as pigs and dogs have been less successful. Initially, domesticated animal pluripotent cell lines were referred to as "embryonic stem-like" cells owing to their similar morphologic characteristics to mouse ESCs, but accompanied by a limited ability to proliferate in vitro in an undifferentiated state. That is, they shared some but not all the characteristics of true ESCs. More recently, advances in reprogramming using exogenous transcription factors, combined with the utilization of small chemical inhibitors of key biochemical pathways, have led to the isolation of iPSCs. In this review, we provide a historical perspective of the isolation of various types of pluripotent stem cells in domesticated animals. In addition, we summarize the latest progress and limitations in the derivation and application of iPSCs.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Induced pluripotent stem cells; Large animals; Pluripotent stem cells; Reprogramming

Mesh:

Year:  2014        PMID: 24274415      PMCID: PMC3883495          DOI: 10.1016/j.theriogenology.2013.09.009

Source DB:  PubMed          Journal:  Theriogenology        ISSN: 0093-691X            Impact factor:   2.740


  106 in total

1.  Using small molecules to improve generation of induced pluripotent stem cells from somatic cells.

Authors:  Caroline Desponts; Sheng Ding
Journal:  Methods Mol Biol       Date:  2010

2.  A cat cloned by nuclear transplantation.

Authors:  T Shin; D Kraemer; J Pryor; L Liu; J Rugila; L Howe; S Buck; K Murphy; L Lyons; M Westhusin
Journal:  Nature       Date:  2002-02-14       Impact factor: 49.962

3.  Induced pluripotent stem cells generated without viral integration.

Authors:  Matthias Stadtfeld; Masaki Nagaya; Jochen Utikal; Gordon Weir; Konrad Hochedlinger
Journal:  Science       Date:  2008-09-25       Impact factor: 47.728

4.  Characterization of canine embryonic stem cell lines derived from different niche microenvironments.

Authors:  Jared T Wilcox; Esther Semple; Cathy Gartley; Brigitte A Brisson; Steven D Perrault; Daniel A F Villagómez; Chandrakant Tayade; Sandy Becker; Robert Lanza; Dean H Betts
Journal:  Stem Cells Dev       Date:  2009-10       Impact factor: 3.272

5.  In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state.

Authors:  Marius Wernig; Alexander Meissner; Ruth Foreman; Tobias Brambrink; Manching Ku; Konrad Hochedlinger; Bradley E Bernstein; Rudolf Jaenisch
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

6.  Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells.

Authors:  Ryoko Araki; Masahiro Uda; Yuko Hoki; Misato Sunayama; Miki Nakamura; Shunsuke Ando; Mayumi Sugiura; Hisashi Ideno; Akemi Shimada; Akira Nifuji; Masumi Abe
Journal:  Nature       Date:  2013-01-09       Impact factor: 49.962

7.  Characterization of bovine induced pluripotent stem cells by lentiviral transduction of reprogramming factor fusion proteins.

Authors:  Hongguo Cao; Pan Yang; Yong Pu; Xueping Sun; Huiqun Yin; Yu Zhang; Yunhai Zhang; Yunsheng Li; Ya Liu; Fugui Fang; Zijun Zhang; Yong Tao; Xiaorong Zhang
Journal:  Int J Biol Sci       Date:  2012-03-21       Impact factor: 6.580

8.  Somatic coding mutations in human induced pluripotent stem cells.

Authors:  Athurva Gore; Zhe Li; Ho-Lim Fung; Jessica E Young; Suneet Agarwal; Jessica Antosiewicz-Bourget; Isabel Canto; Alessandra Giorgetti; Mason A Israel; Evangelos Kiskinis; Je-Hyuk Lee; Yuin-Han Loh; Philip D Manos; Nuria Montserrat; Athanasia D Panopoulos; Sergio Ruiz; Melissa L Wilbert; Junying Yu; Ewen F Kirkness; Juan Carlos Izpisua Belmonte; Derrick J Rossi; James A Thomson; Kevin Eggan; George Q Daley; Lawrence S B Goldstein; Kun Zhang
Journal:  Nature       Date:  2011-03-03       Impact factor: 49.962

Review 9.  Large animal induced pluripotent stem cells as pre-clinical models for studying human disease.

Authors:  Jordan R Plews; Mingxia Gu; Michael T Longaker; Joseph C Wu
Journal:  J Cell Mol Med       Date:  2012-06       Impact factor: 5.310

10.  No immunogenicity of IPS cells in syngeneic host studied by in vivo injection and 3D scaffold experiments.

Authors:  Suganya Thanasegaran; Zhao Cheng; Sachiko Ito; Naomi Nishio; Ken-ichi Isobe
Journal:  Biomed Res Int       Date:  2013-04-18       Impact factor: 3.411

View more
  23 in total

1.  Derivation and characterization of bovine induced pluripotent stem cells by transposon-mediated reprogramming.

Authors:  Thirumala R Talluri; Dharmendra Kumar; Silke Glage; Wiebke Garrels; Zoltan Ivics; Katharina Debowski; Rüdiger Behr; Heiner Niemann; Wilfried A Kues
Journal:  Cell Reprogram       Date:  2015-04       Impact factor: 1.987

Review 2.  Livestock models for exploiting the promise of pluripotent stem cells.

Authors:  R Michael Roberts; Ye Yuan; Nicholas Genovese; Toshihiko Ezashi
Journal:  ILAR J       Date:  2015

Review 3.  Pluripotent stem cells and livestock genetic engineering.

Authors:  Delia A Soto; Pablo J Ross
Journal:  Transgenic Res       Date:  2016-02-19       Impact factor: 2.788

4.  Xenotransplantation: Progress Along Paths Uncertain from Models to Application.

Authors:  Jeffrey L Platt; Marilia Cascalho; Jorge A Piedrahita
Journal:  ILAR J       Date:  2018-12-31

5.  Pharmacologic treatment of donor cells induced to have a Warburg effect-like metabolism does not alter embryonic development in vitro or survival during early gestation when used in somatic cell nuclear transfer in pigs.

Authors:  Bethany R Mordhorst; Stephanie L Murphy; Renee M Ross; Joshua A Benne; Melissa S Samuel; Raissa F Cecil; Bethany K Redel; Lee D Spate; Clifton N Murphy; Kevin D Wells; Jonathan A Green; Randall S Prather
Journal:  Mol Reprod Dev       Date:  2018-03-05       Impact factor: 2.609

Review 6.  Application of genome-editing systems to enhance available pig resources for agriculture and biomedicine.

Authors:  Kiho Lee; Kayla Farrell; Kyungjun Uh
Journal:  Reprod Fertil Dev       Date:  2019-01       Impact factor: 2.311

7.  Production of interspecies somatic/pluripotent heterokaryons using polyethylene glycol (PEG) and selection by imaging flow cytometry for the study of nuclear reprogramming.

Authors:  Cristina Villafranca; Melissa R Makris; Maria Jesus Garrido Bauerle; Roderick V Jensen; Willard H Eyestone
Journal:  Cytotechnology       Date:  2020-10-27       Impact factor: 2.058

8.  Primary Bovine Extra-Embryonic Cultured Cells: A New Resource for the Study of In Vivo Peri-Implanting Phenotypes and Mesoderm Formation.

Authors:  Isabelle Hue; Danièle Evain-Brion; Thierry Fournier; Séverine A Degrelle
Journal:  PLoS One       Date:  2015-06-12       Impact factor: 3.240

9.  The transformational impact of site-specific DNA modifiers on biomedicine and agriculture.

Authors:  Kathryn Polkoff; Jorge A Piedrahita
Journal:  Anim Reprod       Date:  2018-08-16       Impact factor: 1.807

Review 10.  Canine Pluripotent Stem Cells: Are They Ready for Clinical Applications?

Authors:  Dean H Betts; Ian C Tobias
Journal:  Front Vet Sci       Date:  2015-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.